|  Help  |  About  |  Contact Us

Publication : Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment.

First Author  Huang W Year  2000
Journal  Neuroreport Volume  11
Issue  3 Pages  445-8
PubMed ID  10718292 Mgi Jnum  J:103600
Mgi Id  MGI:3610466 Doi  10.1097/00001756-200002280-00004
Citation  Huang W, et al. (2000) Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment. Neuroreport 11(3):445-8
abstractText  The segmental trisomy Ts65Dn mouse is a novel model of Down syndrome (DS). The purpose of this study was to measure brain levels of myo-inositol (ml), N-acetylaspartate (NAA), and other metabolites in Ts65Dn mice using in vivo 1H magnetic resonance spectroscopy (MRS), and to determine whether lithium (Li) treatment alters brain ml level. The ratio of ml over total creatine (Cr), ml/Cr, was significantly elevated (mean change +38%), while NAA/Cr was significantly decreased (mean change -18%) in Ts65Dn mice (n=5) compared with control mice (n= 7). This is consistent with 1H MRS findings in DS human adults. Brain ml/Cr of the entire sample group (n= 12) was reduced (mean change -15%) following Li treatment, supporting the Li-induced ml depletion hypothesis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression